Results 51 to 60 of about 7,666 (128)

Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection

, 2008
The immunogenicity and protective efficacy of a DNA vaccine encoding a genetically inactivated S1 domain of pertussis toxin was evaluated using a murine respiratory challenge model of Bordetella pertussis infection.
Trilochan K. S. Mukkur, Chen, Austen Y., Scott R. Fry, Austen Y. Chen, Grant Daggard, Daggard, Grant, Fry, Scott R., Mukkur, Trilochan K. S.   +7 more
core   +1 more source

Acellular pertussis vaccine efficacy: An updated systematic review and meta -analysis. [PDF]

Med J Islam Repub Iran, 2016
Background: Recent studies indicate an increased incidence of pertussis disease in recent years. The aim of this study was to evaluate the efficacy of the acellular vaccine for children (as a replacement of current whole cell vaccine in the Expanded ...
Mansour-Ghanaei R, Moradi-Lakeh M, Shakerian S, Karimi A, Esmaeeli S, Shokraneh F, Mahmoudi S, Yaghoubi M.   +7 more
europepmc   +1 more source

Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children

, 2006
Background The transition from a whole-cell to a 5-component acellular pertussis vaccine provided a unique opportunity to compare the effect that each type of vaccine had on the incidence of pertussis, under routine conditions, among children less than ...
Shah, Syed, Vickers, D, G. Ross, Allen, C. Mainar-Jaime, Raúl, Shah, S, Mainar-Jaime, RC, Vickers, David, Neudorf, C, Ross, AG, Neudorf, Cordell   +9 more
core   +1 more source

Antibodies Recognizing Protective Pertussis Toxin Epitopes Are Preferentially Elicited by Natural Infection versus Acellular Immunization

, 2011
Despite more than 50 years of vaccination, disease caused by the bacterium Bordetella pertussis persists, with rates increasing in industrialized countries over the past decade.
Jennifer A. Maynard, Yoder, Sandra M., Rock, Michael T., Chang, Christine, Michael T. Rock, Maynard, Jennifer A., Christine Chang, Ra M. Yoder, Sandra M. Yoder, Sutherland, Jamie N., Jamie N. Sutherl, Jamie N. Sutherland   +11 more
core   +1 more source

Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children : monovalent acellular pertussis vaccine study group

, 1995
Immunization against pertussis has been re-recommended for healthy children in Germany in 1991. In addition the former restriction of immunizing only in the first 2 years of life was abolished.
Angersbach, P., Stehr, K., Uhlenbusch, R., Eckhardt, T., Hackell, J., Heininger, U.   +5 more
core  

Poster Session 3

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Health Policy and Technological Change: Evidence from the Vaccine Industry [PDF]

Rapid technological progress has been a defining feature of the medical sector over the last century, yet we know little about the determinants of the development of these new technologies.
Amy Finkelstein
core  

Poster Session 1

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Development of An Acellular Pertussis-vaccine and its Administration As a Booster in Healthy-adults

, 1991
An acellular pertussis vaccine which contains highly purified pertussis toxoid (PT) and filamentous haemagglutinin (FHA) has been developed. These proteins have been shown to be stable, with essentially no significant reversion of the pertussis toxoid ...
Puttolaurila, A., Teuwen, DE., Delem, Andrée, Bogaerts, H., Ruuskanen, Olli, Capiau, Carine, Delem, A., Capiau, C., Putto-Laurila, Anne, Simoen, E., Andre, FE., Teuwen, Dirk D.E., Ruuskanen, O., Simoen, Etienne, Noël, André, Andre, Francis, Petre, Jean-Emmanuel, Vandevoorde, Danièle, Pêtre, Jean, Bogaerts, Hugues, Vandevoorde, D.   +20 more
core   +1 more source

Poster Session 2

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source